Andrew S. Davis - Mar 1, 2024 Form 4 Insider Report for Silk Road Medical Inc (SILK)

Role
Chief Commercial Officer
Signature
/s/Mhairi Jones, by power of attorney
Stock symbol
SILK
Transactions as of
Mar 1, 2024
Transactions value $
-$94,103
Form type
4
Date filed
3/5/2024, 06:25 PM
Previous filing
Sep 15, 2023
Next filing
Jul 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILK Common Stock Award $0 +62.2K +26.92% $0.00 293K Mar 1, 2024 Direct F1
transaction SILK Common Stock Sale -$94.1K -5.48K -1.87% $17.17 288K Mar 5, 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of SILK common stock. 25% of the shares shall vest on March 1, 2025 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F2 Represents shares that have been sold by the Reporting Person to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.